Meg Finch-Jones

Medicine · Health Sciences

14h-index6.8kcitations41works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hepatocellular Carcinoma Treatment and Prognosis(23), Colorectal Cancer Treatments and Studies(22), Pancreatic and Hepatic Oncology Research(15), Gastric Cancer Management and Outcomes(6), Radiomics and Machine Learning in Medical Imaging(5)

Publications40 total

Relieving Bowel Obstruction with EUS and Stenting
Global Journal of Medical and Clinical Case Reports·2025Open Access
Use of EUS and Stent Insertion in Symptom Management of Malignant Bowel Obstruction Following Cancer Recurrence after Whipple's Pancreaticoduodenectomy
HPB·2023Open Access
Untitled
UCL Discovery (University College London)·2022· 159 citedOpen Access
281 Evaluating a Diagnostic Algorithm for Adult Appendicitis – A Quality Improvement Project
British journal of surgery·2021Open Access
Long Term Outcomes and Exploratory Analyses of the Randomised Phase 3 BILCAP Study
SSRN Electronic Journal·2021Open Access
Microscopic resection margins adversely influence survival rates after surgery for colorectal liver metastases: An open ambidirectional Cohort Study
International Journal of Surgery·2020· 4 cited
Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis (New EPOC): long-term results of a multicentre, randomised, controlled, phase 3 trial
The Lancet Oncology·2020· 227 citedOpen Access
Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study
The Lancet Oncology·2019· 1.2k citedOpen Access
A Prospective Audit of Surgical Poor Prognosis: Management at the End of Life
International Journal of Surgery·2017· 1 cited
Perioperative chemotherapy with or without cetuximab in patients (pts) with resectable colorectal liver metastasis (CRLM): Mature analysis of overall survival (OS) in the New EPOC randomised controlled trial
Annals of Oncology·2017· 6 citedOpen Access
Surgical quality and the impact of liver resection on outcome in the new EPOC study
Annals of Oncology·2017
Missed pancreatic ductal adenocarcinoma (PDAC) in Hereditary Pancreatitis (HP) kindreds indicate the importance of a systematic approach to secondary screening
Pancreatology·2017
Validation of the EORTC QLQ-BIL21 questionnaire for measuring quality of life in patients with cholangiocarcinoma and cancer of the gallbladder
British Journal of Cancer·2016· 40 citedOpen Access
Patterns of progression, treatment of progressive disease and post-progression survival in the New EPOC study
British Journal of Cancer·2016· 10 citedOpen Access
Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983)
2016· 2 cited
Cetuximab Is Contraindicated in the Perioperative Treatment of Colorectal Liver Metastases
Journal of Clinical Oncology·2015· 7 citedOpen Access
Association between c-Met expression, miR-31-3p expression and progression free survival in the New EPOC study.
Journal of Clinical Oncology·2015
Analysis of Progression Free Survival in the New Epoc Study in an All Ras Wild-Type Population
Annals of Oncology·2014
Analysis of progression-free survival in the new EPOC study in an “all wild-type” population.
Journal of Clinical Oncology·2014· 2 cited
Patterns of progression, treatment of progressive disease, and postprogression survival in the new EPOC study.
Journal of Clinical Oncology·2014· 3 cited
page 1 of 2Next →

Frequent Co-authors

John Primrose(24), David Cunningham(15), Juan W. Valle(15), John Bridgewater(15), Stephen Falk(14), Timothy Iveson(11), Tim Maughan(11), Joanne Hornbuckle(10), S. Pugh(10), Tamas Hickish(9), Bernard Nordlinger(8), Thomas Gruenberger(8), Bengt Glimelius(7), Wolf O. Bechstein(7), Euan Walpole(7), Derek O’Reilly(7), Myrddin Rees(7), Louise Stanton(7), Halfdan Sørbye(6), Graeme J. Poston(6)